Lecigimon

Entacapone, the active ingredient in Lecigimon, is a combination antiparkinson agent presented as a tablet for oral use. It is used to treat Parkinson's disease, particularly in patients with advanced disease who experience motor fluctuations despite levodopa therapy.

GNH USA supplies Lecigimon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on reliable quality, regulatory compliance and timely delivery across multiple regions. Our global network ensures consistent product availability and support for healthcare providers managing Parkinson's disease.

Lecigimon, a combination antiparkinson agent, is indicated for the management of Parkinson's disease with motor fluctuations.

- Parkinson's disease (advanced): Improves motor control and reduces OFF periods. - Parkinson's disease (adjunct therapy): Enhances levodopa efficacy by inhibiting peripheral metabolism. - Parkinson's disease (motor fluctuations): Provides more stable dopamine levels to lessen dyskinesia.

Lecigimon may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: sensation of light‑headedness, especially on standing. - Orthostatic hypotension: drop in blood pressure upon standing. - Hallucinations: visual disturbances, particularly in older patients.

Serious or Rare Side Effects: - Severe liver injury: elevated transaminases requiring monitoring. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Severe depression or suicidal ideation: monitor mood changes closely. - Anaphylactic reaction: immediate medical attention if signs of allergy appear. - Hyperpyrexia: unexplained high fever needing urgent care.

Before prescribing Lecigimon, consider the following precautions.

- Dose adjustment in renal impairment: reduce dose as needed based on renal function. - Monitor hepatic function: perform periodic liver enzyme tests. - Assess for psychiatric symptoms: watch for depression, anxiety, or hallucinations. - Avoid abrupt discontinuation: sudden stop may worsen Parkinsonian symptoms. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lecigimon can interact with several medication classes.

Major Interactions (Avoid): - MAO‑B inhibitors: increased risk of hypertensive crisis. - Non‑selective MAO inhibitors: contraindicated due to severe pressor effects. - Iron supplements: markedly reduce levodopa absorption; separate dosing by at least 2 hours.

Moderate Interactions (Monitor Closely): - Anticholinergics: may exacerbate confusion or cognitive impairment. - SSRIs and other serotonergic agents: potential for serotonin syndrome. - NSAIDs: increase risk of gastrointestinal bleeding, especially in elderly patients.